Clinical Trials Browser

Terminated × Non-Muscle Invasive Bladder Neoplasms × 1 year × Clear all

NCT02106572 2026-05-22

TIM

Phase 3 Terminated

Non-Muscle Invasive Bladder Neoplasms

NCT06026332 2026-02-17

ABLE-41

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04412070 2025-11-21

ALU

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05014139 2025-11-20

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Phase 1 Terminated

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell